甲使用与身体功能和虚弱的关联在注射毒品的人中
Grace L Kulik1, Hsing-Yu Hsu2, Jacqueline Rudolph2
1Division of Infectious Diseases, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA.
Addiction (Abingdon, England)
|December 24, 2025
概括
在注射毒品的人中,甲的使用与脆弱和握力减弱的可能性更高有关. 在接受甲治疗的人群中,建议对脆弱性进行早期查.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 注射药物使用者 (PWID) 面临着由于艾滋病毒,HCV,物质使用和多种药物等因素而造成的早期虚弱的高负担.
- 甲是治疗阿片类药物使用障碍的药物,由于其全身毒性,可能会加速衰老.
研究的目的:
- 调查甲使用与PWID的脆弱性之间的关联.
- 为了确定甲对PWID的身体功能的影响.
主要方法:
- 对与静脉内体验 (ALIVE) 相关的艾滋病队伍 (2005-2020年) 的回顾性分析.
- 使用多变量混合效应逻辑回归,调整人口统计,BMI,物质使用,艾滋病毒和并发症.
- 评估的脆弱性使用炸脆弱性表型,握力和4米步行速度.
主要成果:
- 甲使用与25%更高的虚弱概率有关.
- 50岁时使用甲的人与54岁时不使用甲的人的脆弱率相似.
- 甲使用与较低的平均握力相关,但与较慢的步行速度无关.
结论:
- 使用美沙的PWID更容易出现早期发作的脆弱性.
- 表明需要在这个人群中早期查甲使用者的虚弱和老年状况.
相关概念视频
Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
216
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
216
Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
205
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
205
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
165
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
209
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
209


